Rep. Josh Gottheimer sold Syneos Health (SYNH)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Dec 6, 2022
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Dec 6, 2022
- Disclosed
- Jan 13, 2023
- Days to disclose
- 38
- Asset type
- Stock
- As filed
- Syneos Health, Inc. - Class A
- Industry
- Medical - Diagnostics & Research · Healthcare
Other trades in this filing
- Jan 13, 2023$1K–$15K
Sold (partial) Pharmaceutical GRP LTD (CSPCY)
$1K–$15K · Traded Dec 30, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Sold (partial) Supernus Pharmaceuticals SUPN
$1K–$15K · Traded Dec 23, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Bought Automatic Data Processing ADP
$1K–$15K · Traded Dec 20, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 9, 2022 · disclosed Jan 13, 2023 · Joint
Got $4K from the company’s PAC - Jan 13, 2023$1K–$15K
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Dec 7, 2022 · disclosed Jan 13, 2023 · Joint
Got $10K from the company’s PAC - Jan 13, 2023$1K–$15K
Bought Shoals Technologies Group SHLS
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Sold (partial) Halozyme Therapeutics HALO
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
$1K–$15K · Traded Dec 5, 2022 · disclosed Jan 13, 2023 · Joint
- Jan 13, 2023$1K–$15K
Bought Fidelity National Information Services FIS
$1K–$15K · Traded Dec 1, 2022 · disclosed Jan 13, 2023 · Joint
Recent Congress trades in SYNH
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Feb 17, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jan 23, 2023 · disclosed Feb 17, 2023 · Joint
Company context for SYNH
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
SYNH: third_quarter 2026 lobbying report
Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.
Public: Oct 20, 2026, 5:31 PM EDTOriginal source ↗SYNH: second_quarter 2026 lobbying report
Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.
Public: Jul 20, 2026, 3:25 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.